Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...
Superbugs, bacteria that are immune to multiple antibiotics, pose a great challenge to modern medicine. Researchers from the ...
Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback